20.5 C
New York
Wednesday, June 3, 2026

Tag: global development

newssourceFORcompanyinformationcontent1marketreleases

LI-NING Announces Long-Term Partnership with Stephen Curry and Curry Brand

BEIJING, June 2, 2026 /PRNewswire/ -- LI-NING today announced a long-term partnership with 4x Championship titles, 2x MVP and Olympic Gold Medalist Stephen Curry...

LI-NING Announces Long-Term Partnership with Stephen Curry and Curry Brand

BEIJING, June 2, 2026 /PRNewswire/ -- LI-NING today announced a long-term partnership with 4x Championship titles, 2x MVP and Olympic Gold Medalist Stephen Curry...

LI-NING Announces Long-Term Partnership with Stephen Curry and Curry Brand

BEIJING, June 1, 2026 /PRNewswire/ -- LI-NING today announced a long-term partnership with 4x Championship titles, 2x MVP and Olympic Gold Medalist Stephen Curry...

LI-NING Announces Long-Term Partnership with Stephen Curry and Curry Brand

BEIJING, June 1, 2026 /CNW/ -- LI-NING today announced a long-term partnership with 4x Championship titles, 2x MVP and Olympic Gold Medalist Stephen Curry...

Fosun Pharma’s Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License...

POWERCHINA Drives Green Energy Transition in Europe and Central Asia Amid Growing Global Climate Pressures

BEIJING, Aug. 11, 2025 /PRNewswire/ -- Power Construction Corporation of China ("POWERCHINA" or "the Company") is accelerating the global transition to a low-carbon, resilient energy...

POWERCHINA Drives Green Energy Transition in Europe and Central Asia Amid Growing Global Climate Pressures

BEIJING, Aug. 10, 2025 /PRNewswire/ -- Power Construction Corporation of China ("POWERCHINA" or "the Company") is accelerating the global transition to a low-carbon, resilient energy...

Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025

Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel, Aug. 7, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a...

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies CAMBRIDGE, Mass. and BIRMINGHAM, Ala. and RAICHUR, India,...

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies CAMBRIDGE, Mass. and BIRMINGHAM, Ala. and RAICHUR, India,...

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies CAMBRIDGE, Mass. and BIRMINGHAM, Ala. and RAICHUR, India,...

Smart Mobility Powers Dual Circulation

The World Intelligent Vehicle Conference 2025 Kicks Off CHONGQING, China, Aug. 1, 2025 /PRNewswire/ -- China's intelligent vehicle industry is embracing global cooperation with openness...

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: 

Harbour BioMed to Present Phase II Data of HBM4003 and Tislelizumab Combination in MSS Metastatic Colorectal Cancer at ESMO 2025

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 29, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsGlobal development

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers